FDA Approves Two-In-One Diabetes Treatment
The U.S. Food and Drug Administration has approved a new drug from AstraZeneca that combines two drugs in one to
Read more
Astrazeneca
Once-Weekly Tanzeum for Type 2s Now Available
Tanzeum (albiglutide), a once-weekly injectable drug for type 2s from GSK (GlaxoSmithKline), USA is now available at pharmacies throughout the
Read more
FDA Delays Final OK for Type 2 Drug Empagliflozin
The FDA will delay allowing the type 2 drug empagliflozin to enter the U.S. market until “previously observed deficiencies” at
Read more
FDA OKs Dapagliflozin as Type 2 Drug
The Food and Drug Administration has approved the entry of dapagliflozin, a drug for treating type 2 diabetes, into the
Read more
Dapagliflozin Teams Well With Metformin, Sulfonylurea
According to researchers, dapagliflozin, a diabetes drug developed jointly by two pharmaceutical companies has shown significant benefits when teamed with
Read more